South Africa’s government has estimated that universities and science councils could lose about $107 million in U.S. research ...

Just before a major HIV vaccine trial was to begin, U.S. funding cuts halted South Africa’s BRILLIANT project, threatening ...

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year anti-HIV jab, lenacapavir. Research shows the shot could help end Aids in ...

A larger role for China, perhaps, and the fraught issue of integrating HIV services into services for other diseases.

The withdrawal of U.S. funding under the Trump administration has halted key HIV vaccine trials in South Africa, part of a ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...

Even more concerning? The loss of data. The US funded most HIV tracking systems in Africa, and many have now stopped collecting patient and hospital records.

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global ...

HIV pharma leaders are at Kigali, Rwanda for IAS 2025, touting their latest advancements in HIV and PrEP development on the ...

Rep. Marjorie Taylor Greene (R-GA) ranted about how the U.S. sends money to Africa to prevent the spread of HIV, arguing that ...

Global deaths from AIDS have dropped to their lowest levels in more than 30 years, but US funding cuts could soon reverse that progress.

The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January ...